Safety Monitoring of Medicinal Products: Guidelines for Setting Up and Running a Pharmacovigilance Centre
(2000; 28 pages) [French]
Table of Contents
View the documentINTRODUCTION
View the document1. WHY PHARMACOVIGILANCE?
View the document2. DEFINITION AND AIMS
Open this folder and view contents3. HOW TO START A PHARMACOVIGILANCE CENTRE
Open this folder and view contents4. REPORTING OF ADVERSE DRUG REACTIONS
Open this folder and view contents5. SPECIAL ISSUES IN REPORTING
Close this folder6. PRACTICALITIES IN THE ORGANISATION OF A PHARMACOVIGILANCE CENTRE
View the document6.1 Staff
View the document6.2 Useful equipment (includes)
View the document6.3 Continuity
View the document6.4 Advisory Committees
View the document6.5 Information service
View the document6.6 Communications
View the document6.7 Poison Control and Drug Information Centres
Open this folder and view contents7. ASSESSMENT OF CASE REPORTS
Open this folder and view contents8. USE OF THE DATA
Open this folder and view contents9. RELATIONS WITH OTHER PARTIES
View the document10. OTHER SOURCES OF INFORMATION
View the document11. FUNDING
View the documentREFERENCES
View the documentGLOSSARY
View the documentCAUSALITY CATEGORIES
View the documentWHO CONTACTS
 

6.6 Communications

A bulletin or newsletter distributed to all healthcare professionals or a regular column in reputed (medical and pharmaceutical) journals are good means for the dissemination of information. Prompt data-sheet amendments are important, but data-sheets may be printed infrequently and their educational impact may not be large. In urgent cases of sufficient importance ‘Dear Doctor’ letters may alert the profession.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017